Literature DB >> 20453309

High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany.

M H Maurer1, K Hoffmann, K Sperling, R Varon.   

Abstract

Nijmegen breakage syndrome (NBS), a rare autosomal recessive chromosomal instability disorder, is caused by mutations in the NBN gene. Most patients known so far are of Slavic origin and carry the major founder mutation c.657-661del5. Due to an unexpectedly high incidence of NBS patients (homozygous for the c.657-661del5 mutation) in a Northeast Bavarian region in Southeast Germany, we estimated the prevalence of this mutation in this area and compared it to another German region. We found a high carrier frequency of 1/176 for the c.657-661del5 mutation among newborns in Northeast Bavaria, while the frequency of the mutation in Berlin was 1/990. We further studied families from a Slavic population isolate, the Sorbs, in the Lusatian region in Northeast Saxony, and revealed a prevalence of the c.657-661del5 mutation of 1/34. Whereas the Slavic origin of the Sorbs has been known, we attribute the surprisingly high frequencies of c.657-661del5 mutation in Bavaria (similar to frequencies of this mutation in various Eastern European countries) to a high percentage of people of Slavic origin in Northeast Bavaria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20453309     DOI: 10.1007/BF03195730

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  25 in total

1.  Correspondence re: R. Varon et al., Mutations in the Nijmegen breakage syndrome gene (NBS1) in childhood acute lymphoblastic leukemia. Cancer Res., 61: 3570-3572, 2001.

Authors:  G Malcolm Taylor; Helen P O'Brien; Melvyn F Greaves; Paul F Ravetto; Osborn B Eden
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

2.  Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome.

Authors:  R Varon; C Vissinga; M Platzer; K M Cerosaletti; K H Chrzanowska; K Saar; G Beckmann; E Seemanová; P R Cooper; N J Nowak; M Stumm; C M Weemaes; R A Gatti; R K Wilson; M Digweed; A Rosenthal; K Sperling; P Concannon; A Reis
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

3.  Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer.

Authors:  F Carlomagno; J Chang-Claude; A M Dunning; B A Ponder
Journal:  Genes Chromosomes Cancer       Date:  1999-08       Impact factor: 5.006

4.  Germline 657del5 mutation in the NBS1 gene in breast cancer patients.

Authors:  Bohdan Górski; Tadeusz Debniak; Bartlomiej Masojć; Marek Mierzejewski; Krzysztof Medrek; Cezary Cybulski; Anna Jakubowska; Grzegorz Kurzawski; Maria Chosia; Rodney Scott; Jan Lubiński
Journal:  Int J Cancer       Date:  2003-09-01       Impact factor: 7.396

5.  Positional cloning of the gene for Nijmegen breakage syndrome.

Authors:  S Matsuura; H Tauchi; A Nakamura; N Kondo; S Sakamoto; S Endo; D Smeets; B Solder; B H Belohradsky; V M Der Kaloustian; M Oshimura; M Isomura; Y Nakamura; K Komatsu
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

6.  Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.

Authors:  Jerzy Nowak; Maria Mosor; Iwona Ziółkowska; Malgorzta Wierzbicka; Monika Pernak-Schwarz; Marta Przyborska; Krzysztof Roznowski; Andrzej Pławski; Ryszard Słomski; Danuta Januszkiewicz
Journal:  Eur J Cancer       Date:  2008-02-15       Impact factor: 9.162

7.  An increased risk for malignant neoplasms in heterozygotes for a syndrome of microcephaly, normal intelligence, growth retardation, remarkable facies, immunodeficiency and chromosomal instability.

Authors:  E Seemanová
Journal:  Mutat Res       Date:  1990-05       Impact factor: 2.433

8.  Nijmegen Breakage Syndrome mutations and risk of breast cancer.

Authors:  Natalia Bogdanova; Sergei Feshchenko; Peter Schürmann; Regina Waltes; Britta Wieland; Peter Hillemanns; Yuri I Rogov; Olaf Dammann; Michael Bremer; Johann H Karstens; Christof Sohn; Raymonda Varon; Thilo Dörk
Journal:  Int J Cancer       Date:  2008-02-15       Impact factor: 7.396

9.  Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin.

Authors:  Tadeusz Debniak; Bohdan Górski; Cezary Cybulski; Anna Jakubowska; Grzegorz Kurzawski; Marcin Lener; Marek Mierzejewski; Bartosz Masojć; Krzysztof Medrek; Józef Kładny; Elzbieta Załuga; Romuald Maleszka; Maria Chosia; Jan Lubiński
Journal:  Melanoma Res       Date:  2003-08       Impact factor: 3.599

10.  Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS).

Authors:  Bozenna Dembowska-Baginska; Danuta Perek; Agnieszka Brozyna; Anna Wakulinska; Dorota Olczak-Kowalczyk; Malgorzata Gladkowska-Dura; Wieslawa Grajkowska; Krystyna H Chrzanowska
Journal:  Pediatr Blood Cancer       Date:  2009-02       Impact factor: 3.167

View more
  3 in total

Review 1.  Nijmegen breakage syndrome (NBS).

Authors:  Krystyna H Chrzanowska; Hanna Gregorek; Bożenna Dembowska-Bagińska; Maria A Kalina; Martin Digweed
Journal:  Orphanet J Rare Dis       Date:  2012-02-28       Impact factor: 4.123

2.  The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?

Authors:  Eva Seemanova; Raymonda Varon; Jan Vejvalka; Petr Jarolim; Pavel Seeman; Krystyna H Chrzanowska; Martin Digweed; Igor Resnick; Ivo Kremensky; Kathrin Saar; Katrin Hoffmann; Véronique Dutrannoy; Mohsen Karbasiyan; Mehdi Ghani; Ivo Barić; Mustafa Tekin; Peter Kovacs; Michael Krawczak; André Reis; Karl Sperling; Michael Nothnagel
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

3.  Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center.

Authors:  Elissaveta Naumova; Spaska Lesichkova; Veneta Milenova; Petya Yankova; Marianna Murdjeva; Snezhina Mihailova
Journal:  Front Immunol       Date:  2022-09-22       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.